Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Mexico expects to reach a trade agreement with the United States, President Sheinbaum said.
2026-08-24
Mexico expects to reach a trade agreement with the United States, President Sheinbaum said.
Back
Other News
2026-08-24
Goldman Sachs believes that the 2026 World Robot Conference demonstrates that the humanoid robot industry has clearly shifted from "technology demonstration" to commercialization and ROI validation. Companies are focusing their discussions on quantif
Goldman Sachs believes that the 2026 World Robot Conference demonstrates that the humanoid robot industry has clearly shifted from "technology demonstration" to commercialization and ROI validation. Companies are focusing their discussions on quantifiable metrics such as task completion rate, work efficiency, runtime, and payback period, indicating that the industry is entering a real-world application validation phase. Among these, logistics sorting has emerged as one of the clearest early commercialization directions. Current company goals include processing approximately 1300-1800 packages per hour, a success rate of approximately 95%-98%, operating for more than 10 hours per day with three shifts, and a design life of approximately 4-5 years. Goldman Sachs predicts that this scenario will enter small-batch production by the end of 2026 and larger-scale mass production in 2027, with the commercialization pace primarily depending on whether the actual ROI is realized. (The above views are from a Goldman Sachs report dated August 23.)
2026-08-25
The A-share innovative drug sector weakened in early trading, with Harbin Sanlian Pharmaceutical Co., Ltd. hitting the daily limit down, and Zhongguancun Pharmaceutical Group Co., Ltd., Zhongsheng Pharmaceutical Co., Ltd., Yibai Pharmaceutical Co., L
The A-share innovative drug sector weakened in early trading, with Harbin Sanlian Pharmaceutical Co., Ltd. hitting the daily limit down, and Zhongguancun Pharmaceutical Group Co., Ltd., Zhongsheng Pharmaceutical Co., Ltd., Yibai Pharmaceutical Co., Ltd., CSPC Pharmaceutical Innovation Co., Ltd., Sanyuan Gene Co., Ltd., and Lemei Pharmaceutical Co., Ltd. following suit.
Chat with us
, powered by
LiveChat